Boehringer Ingelheim GmbH – SWOT Framework Analysis

Boehringer Ingelheim GmbH – SWOT Framework Analysis

  • February 2015 •
  • 25 pages •
  • Report ID: 291038
Headquartered in Germany, Boehringer Ingelheim GmbH is a leading manufacturer of pharmaceuticals for both human and animal health. The company specializes in the development of medicines in the areas of cardiovascular disease, diabetes, stroke prevention, benign prostate hyperplasia, and others. Some of the most famous brand names of the company include Zantac, Mucosolvan, Dulcolax, Buscopan, Cymbalta, Pharmaton, Thomapyrin, among others.

SWOT Analysis, is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective of the business venture or project and identifying the internal and external factors that are favorable and unfavorable to achieving that objective.

The aim of Aruvian Research’s SWOT analysis is to identify the key internal and external factors that are important to achieving the objective.

We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=World Industry=Pharmaceutical ParentIndustry=LifeSciences Date=201502 Topic=Forecast Publisher=Aruvian'sR'search Price=1000